Prevailing Pulmonary Diseases Promote Extracorporeal Membrane Oxygenation Machine (ECMO) Market
ECMO machine treatment is employed most in patients affected by internal organ failure or cardiogenic shock followed by patients corresponding to metabolic process failure. This treatment option is also used for patients undergoing a heart transplant or a respiratory organ transplant. According to the information recorded by the American research studies, in 2013, Chronic Obstructive Pulmonary Disease (COPD) was recorded to be the third largest reason behind death across the United States. Additionally, over 24.0 million people are estimated to...
View full press release